Autori: Van Cutsem Eric
Naslov | Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer (Article) |
Autori | Van Cutsem Eric Hidalgo Manuel Canon Jean-Luc Macarulla Teresa Bazin Igor Poddubskaya Elena Manojlovic Nebojsa S Radenkovic Dejan V Verslype Chris Eric Raymond Cubillo Antonio Schueler Armin Zhao Charles Hammel Pascal |
Info | INTERNATIONAL JOURNAL OF CANCER, (2018), vol. 143 br. 8, str. 2053-2064 |
Projekat | Merck KGaA, Darmstadt, Germany [NCT01016483]; EMD Serono, Inc. [NCT01016483] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|